BioCentury
ARTICLE | Company News

Eukarion Inc. other research news

March 25, 1996 8:00 AM UTC

University researchers associated with the company reported Eukarion's EUK-8 small molecule synthetic catalytic scavenger (SCS) halted neuronal damage produced by beta-amyloid peptide (BAP) in an in vitro model of Alzheimer's. EUK-8 also completely blocked BAP free radical accumulation and lipid peroxidation. ...